Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings: a consensus statement.
about
Superior outcomes and lower outpatient costs with scale-up of antiretroviral therapy at the GHESKIO clinic in Port-au-Prince, Haiti.The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.Preferred antiretroviral drugs for the next decade of scale up.Estimation of intracellular concentration of stavudine triphosphate in HIV-infected children given a reduced dose of 0.5 milligrams per kilogram twice daily.Validation of Computational Approaches for Antiretroviral Dose OptimizationSafety of zidovudine dose reduction in treatment-naïve HIV infected patients. A randomized controlled study (MiniZID).Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial.Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate.ARVs: the next generation. Going boldly together to new frontiers of HIV treatment.Evaluation of universal versus genotype-guided efavirenz dose reduction in pregnant women using population pharmacokinetic modelling.
P2860
Q34775595-52686E8F-31C6-4FF4-8742-A7E6BD841D22Q35023687-9EFE12A8-A112-4CE3-84A2-DC270EDD2F03Q36386810-31226918-E3EF-4080-8B7D-F72D0345CB3CQ37544710-51AD53FF-CFED-4676-9F18-1FE7543117C4Q39863986-2B831316-A501-4EC5-A8F3-BD3EDA31C23FQ41007911-86ED0365-060C-4D66-B344-9E9A1F217FCCQ41590742-90EDB705-274F-441A-85DD-C2134F6C01ECQ41929341-ABCB4109-AE31-4C9E-B048-8FFFF7B1A41AQ42037463-2EED8321-32CA-4754-AC5E-28104028BEBEQ43183132-2F82C30B-B627-4519-BA29-CFE5470F1DF2Q46460183-2564A041-4A26-4291-9AFD-C3BCA50B5489
P2860
Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings: a consensus statement.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Optimising the manufacture, fo ...... ttings: a consensus statement.
@en
type
label
Optimising the manufacture, fo ...... ttings: a consensus statement.
@en
prefLabel
Optimising the manufacture, fo ...... ttings: a consensus statement.
@en
P2093
P1476
Optimising the manufacture, fo ...... ttings: a consensus statement.
@en
P2093
Andrew D Levin
Charles Flexner
David H Brown Ripin
Jennifer R Campbell
Keith W Crawford
participants of Conference on Antiretroviral Drug Optimization
P304
P356
10.1016/S1473-3099(12)70134-2
P577
2012-07-01T00:00:00Z